Ubs Group Ag Staar Surgical CO Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Staar Surgical CO stock. As of the latest transaction made, Ubs Group Ag holds 19,043 shares of STAA stock, worth $534,346. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,043

Previous 13,450 41.58%

Holding current value

$534,346

Previous $640,000 10.47%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$29.97 - $47.42 $167,622 - $265,220	5,593 Added 41.58%	19,043 $707,000
Q2 2024 Aug 13, 2024	SELL	$38.07 - $52.25 $402,590 - $552,543	-10,575 Reduced 44.02%	13,450 $640,000
Q1 2024 May 13, 2024	SELL	$27.67 - $39.61 $232,261 - $332,486	-8,394 Reduced 25.89%	24,025 $919,000
Q4 2023 Feb 09, 2024	BUY	$30.6 - $43.78 $982,719 - $1.41 Million	32,115 Added 10564.14%	32,419 $1.01 Million
Q3 2023 Nov 09, 2023	SELL	$39.39 - $58.12 $1.64 Million - $2.43 Million	-41,758 Reduced 99.28%	304 $12,000
Q2 2023 Aug 11, 2023	BUY	$50.45 - $72.82 $989,122 - $1.43 Million	19,606 Added 87.31%	42,062 $2.21 Million
Q1 2023 May 12, 2023	BUY	$51.25 - $79.34 $424,042 - $656,459	8,274 Added 58.34%	22,456 $1.44 Million
Q4 2022 Feb 08, 2023	SELL	$46.82 - $76.2 $909,853 - $1.48 Million	-19,433 Reduced 57.81%	14,182 $688,000
Q3 2022 Nov 10, 2022	BUY	$70.55 - $111.58 $2.31 Million - $3.66 Million	32,810 Added 4075.78%	33,615 $2.37 Million
Q2 2022 Aug 10, 2022	BUY	$50.24 - $80.48 $22,909 - $36,698	456 Added 130.66%	805 $57,000
Q1 2022 May 16, 2022	SELL	$57.98 - $93.5 $963,743 - $1.55 Million	-16,622 Reduced 97.94%	349 $28,000
Q4 2021 Feb 14, 2022	BUY	$88.02 - $127.79 $1.25 Million - $1.82 Million	14,249 Added 523.48%	16,971 $1.55 Million
Q3 2021 Nov 15, 2021	SELL	$122.75 - $162.68 $1.38 Million - $1.83 Million	-11,233 Reduced 80.49%	2,722 $350,000
Q2 2021 Aug 13, 2021	BUY	$105.76 - $154.96 $487,130 - $713,745	4,606 Added 49.27%	13,955 $2.13 Million
Q1 2021 May 12, 2021	SELL	$78.5 - $126.48 $178,587 - $287,742	-2,275 Reduced 19.57%	9,349 $985,000
Q4 2020 Feb 11, 2021	BUY	$55.93 - $82.78 $118,683 - $175,659	2,122 Added 22.33%	11,624 $921,000
Q3 2020 Nov 12, 2020	SELL	$45.65 - $61.81 $682,969 - $924,739	-14,961 Reduced 61.16%	9,502 $538,000
Q2 2020 Jul 31, 2020	SELL	$29.15 - $61.54 $5,800 - $12,246	-199 Reduced 0.81%	24,463 $1.51 Million
Q1 2020 May 01, 2020	SELL	$25.01 - $42.4 $757,978 - $1.29 Million	-30,307 Reduced 55.13%	24,662 $796,000
Q4 2019 Feb 14, 2020	BUY	$24.55 - $38.13 $543,193 - $843,664	22,126 Added 67.37%	54,969 $1.93 Million
Q3 2019 Nov 14, 2019	BUY	$25.78 - $34.8 $670,640 - $905,287	26,014 Added 380.93%	32,843 $846,000
Q2 2019 Aug 14, 2019	SELL	$23.08 - $37.01 $115 - $185	-5 Reduced 0.07%	6,829 $201,000
Q1 2019 May 14, 2019	SELL	$27.81 - $40.78 $427,495 - $626,870	-15,372 Reduced 69.22%	6,834 $234,000
Q4 2018 Feb 14, 2019	BUY	$28.91 - $50.0 $127,377 - $220,300	4,406 Added 24.75%	22,206 $708,000
Q3 2018 Nov 14, 2018	BUY	$30.85 - $50.65 $226,377 - $371,669	7,338 Added 70.14%	17,800 $854,000
Q2 2018 Aug 14, 2018	BUY	$13.95 - $32.65 $132,817 - $310,860	9,521 Added 1011.8%	10,462 $324,000
Q1 2018 May 15, 2018	SELL	$14.35 - $16.5 $33,062 - $38,016	-2,304 Reduced 71.0%	941 $14,000
Q4 2017 Feb 14, 2018	BUY	$12.45 - $17.4 $16,956 - $23,698	1,362 Added 72.33%	3,245 $51,000
Q3 2017 Nov 14, 2017	SELL	$10.25 - $12.8 $748 - $934	-73 Reduced 3.73%	1,883 $23,000
Q2 2017 Aug 14, 2017	SELL	N/A	-1,658 Reduced 45.88%	1,956 $22,000
Q1 2017 Nov 14, 2017	BUY	N/A	3,614	3,614 $35,000

Others Institutions Holding STAA

# of Institutions

255

Shares Held

47.8M

Call Options Held

427K

Put Options Held

206K

View Full List

About STAAR SURGICAL CO

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.35B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

More about STAA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account